Annual revenue surpasses $2 billion for the 12 months ended June 30, 2025, reflecting >40% growth over the prior 12-month period. Provider network grows to >300 across 20 states. New treatment innovations broaden access to cutting-edge cancer care

FORT MYERS, Fla., Aug. 12, 2025 – American Oncology Network (AON), one of the fastest-growing networks of community-based oncology practices in the United States, today announced the achievement of multiple key milestones. Fueled by new and expanding partnerships, groundbreaking treatment innovations, and a steadfast commitment to patient-centered care, AON continues to advance its mission of delivering world-class oncology care to more communities across the country.

With annual revenue surpassing $2 billion for the 12 months ended June 30, 2025, AON continues to demonstrate strong momentum. This revenue represents >40% growth over the 12 months ended June 30, 2024 and is driven by both organic expansion and the addition of numerous practices and providers in new markets. The network now includes more than 300 oncology and hematology providers across 20 states, offering expanded access to advanced treatments and diagnostics.

Looking ahead, AON is inviting new partners to join its growing national network, where they can preserve clinical autonomy and focus on patients while growing revenue with access to best-in-class support infrastructure including an in-house specialty pharmacy, revenue cycle management, prior authorization, innovative data and technology, and more. AON partner practices average a greater than 30% increase in sustainable income after joining. AON maintains a robust pipeline of practices interested in benefitting from AON’s unique value proposition.

“AON’s growth and momentum reflects the strength of our model and the commitment of our partner practices to transform how cancer care is delivered in communities across the country,” said Todd Schonherz, chief executive officer of AON. “We’re not just growing—we’re delivering measurable improvements in patient access, experience and outcomes.”

2025 YTD Growth and Innovation Highlights

• Nationwide Expansion
  The network added dozens of new practices and providers, growing to more than 300 oncology and hematology specialists across 20 states. Recent partnerships include Fort Wayne Medical Oncology and Hematology, MidAmerica Cancer Care, Auerbach Hematology and Oncology, and Conway Hematology Oncology.
  Further, several AON partner practices added new clinic locations, expanded existing ones, and recruited new physicians across the country. Growth will continue through the remainder of 2025, as AON is currently recruiting providers for 16 clinic locations across the country and will welcome four additional new physicians next month.
• Launch of Groundbreaking Immunotherapies
  More than 40 AON-affiliated clinics began offering bispecific T-cell engager (BiTE) therapies, expanding access to advanced immunotherapy in community settings.
• Radiology and Radioligand Therapy Expansion
  AON broadened access to cutting-edge radioligand therapies (RLT), offering targeted treatments for certain metastatic and rare cancers.
• Increased Lab Efficiency Through Cloud-Based Systems
  AON launched a cloud-based laboratory information system to streamline the integration of complex pathology reports, improving efficiency across its pathology and oncology labs.
• Clinical Trial Innovation with AI-Empowered Data Technology for Patient Matching
  To enhance access to clinical trials, AON co-created MiBA, a leader in AI-enabled trial matching and patient navigation. The collaboration supports faster, more precise identification and recruitment for oncology clinical trials.
• Value-Based Care Leadership
  AON had several advancements in value-based care:
  • Achieved nearly $6 million in cost savings for CMS from the CMS Enhancing Oncology Model (EOM) and partnered with a large multi-state commercial value-based care organization, which led to $2.7 million in cumulative savings.
  • Launched self-funded employer contracting consisting of 1 million covered lives, aligned with value-based benefit design principles.
  • Implemented a social risk navigation platform, leading to a 39% improvement in social risk factors contributing to improved health outcomes.
• National Recognition and Research Impact
  AON physicians and executives participated in 14 sessions at the 2025 Community Oncology Alliance (COA) Annual Meeting and presented 24 research studies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. Fifteen additional studies will be presented at ASCO’s Quality of Care Symposium in October 2025.
• CAP Laboratory Reaccreditation
  AON’s central laboratory in Fort Myers, Florida, earned reaccreditation from the College of American Pathologists (CAP), following a rigorous on-site inspection.
• Executive Leadership Expansion
  To support continued growth, AON appointed several senior leaders in the first half of 2025, including Charlie Goddard as general counsel, Terri Casey as chief human resources officer, and Joe Verschleiser as chief growth and performance officer.

A Vision for the Remainder of 2025

AON is positioned to amplify its national impact by advancing clinical innovation, strengthening partnerships and supporting the long-term sustainability of community oncology. Practices that join AON gain access to a robust suite of services and tools that help them grow while delivering exceptional care.

“We remain committed to ensuring that every patient receives personalized, high-quality care while reducing costs and improving outcomes,” said Dr. Stephen “Fred” Divers, chief medical officer of AON. “We’re proud to welcome new providers who share our vision and dedication to advancing care in the communities where patients live.”

For more information about AON, visit AONcology.com.

Financial Disclosure Advisory

This press release contains certain financial results for the twelve month period ended June 30, 2025. The financial results have not been audited or reviewed by the Company’s independent registered public accounting firm. Accordingly, the Company’s independent registered public accounting firm does not express an opinion with respect thereto, and you should not place undue reliance on such financial results. This press release also contains forward-looking statements, including but not limited to statements regarding anticipated growth, future treatment offerings, physician recruitment, and potential financial outcomes. These statements are based on current expectations and projections and are subject to risks and uncertainties that may cause actual results to differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. AON assumes no obligation to update or revise any such statements unless required by law.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:

Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Genesis Cancer and Blood Institute and American Oncology Network Welcome Dr. Tyler Fugere.

HOT SPRINGS, ARK., Aug. 5, 2025 –  Genesis Cancer and Blood Institute, a partner practice of American Oncology Network (AON), is pleased to welcome Board-certified physician Tyler Fugere, MD, to its physician care team. She joins an experienced group of physicians including Drs. Brad Baltz, Jim Chen, Timothy Webb, Robert Muldoon, Stephen “Fred” Divers, Lynn Cleveland, Lingyi Chen, Sunil Kakadia, and Kristen Sager.

Dr. Fugere is a Board-certified medical oncologist and hematologist. She earned her medical degree from the University of Arkansas for Medical Sciences (UAMS) in Little Rock, where she also completed her internal medicine residency and hematology-oncology fellowship. Originally from Benton, Arkansas, she graduated summa cum laude from Benton High School and later earned her undergraduate degree from Ouachita Baptist University in Arkadelphia.

She is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the National Comprehensive Cancer Network. Dr. Fugere is passionate about providing personalized, patient-centered care in the community setting.

“I’m honored to join Genesis Cancer and Blood Institute,” said Dr. Fugere. “Genesis has a long-standing reputation for excellence in patient care, and its values align perfectly with my own. I look forward to being part of a team that puts patients first while offering the latest in evidence-based treatment.”

With 10 medical oncologists and five advance practice providers across 11 locations in Arkansas,  Genesis Cancer and Blood Institute offers comprehensive services for cancer diagnosis, treatment, clinical trials, survivorship and patient support—all delivered close to home.

“We’re excited to welcome Dr. Fugere to the Genesis team,” said Dr. Timothy Webb, medical oncologist at Genesis. “Her knowledge, compassion and dedication to personalized care make her a perfect addition to our group. I know our patients will benefit from her expertise.”

“On behalf of AON, I’m pleased to welcome Dr. Fugere to Genesis and to our national network,” said Stephen “Fred” Divers, MD, medical oncologist at Genesis and AON’s chief medical officer. “Her commitment to delivering high-quality, community-based care reflects AON’s mission to make exceptional cancer treatment accessible to patients where they live. She will be an invaluable asset to both our team and the patients we serve.”

Dr. Fugure began seeing patients at the Genesis Benton and Little Rock clinics on Aug. 1, 2025.

For more information about AON, visit AONcology.com. To learn more about Genesis Cancer and Blood Institute, visit genesiscancerblood.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Genesis Cancer and Blood Institute
Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. Brad Baltz, Dr. Jim Chen, Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland, Dr. Lingyi Chen, Dr. Sunil Kakadia, Dr. Kristen Sager, and Dr. Tyler Fugere. Learn more at genesiscancerblood.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Local oncology practice enhances state-of-the-art location to include radiology services that improve cancer care for the Lee County community.

FORT MYERS, FL, July 15, 2025 – Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has expanded its Fort Myers clinic at 14551 Hope Center Loop to include radiology services. Current and prospective patients can call (239) 264-7026 for more information or to schedule an appointment.

Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO are now seeing patients at the new location.

The expanded clinic offers PET services, 12 exam rooms for patient consultations, nearly 30 infusion chairs and an on-site lab.

“Our Fort Myers practice now includes radiology services, allowing us to better meet the needs of our patients throughout Lee County,” said medical director, Dr. Van den Bergh. “Delivering compassionate, high-quality care remains our top priority. This expansion enables us to provide that care in a more comprehensive and comfortable setting. We’re grateful for the trust our patients place in us and look forward to welcoming them to the expanded space.”

Florida Oncology and Hematology operates five clinics serving patients in Cape Coral, Clearwater, Fort Myers, Naples and surrounding areas. The practice is dedicated to providing personalized care plans tailored to each patient’s unique needs. As a community-based oncology group, it offers high-quality, affordable care in a supportive and accessible environment.

The practice is a partner of American Oncology Network, one of the fastest-growing community oncology networks in the United States. Through this partnership, patients have access to expanded services such as an in-house specialty pharmacy, which provides home delivery of select medications, along with other supportive care resources.

“We’re proud to continue growing alongside our community,” said Dr. Parsa. “The addition of PET services not only allows us to provide diagnostic PET and CT imaging, but it also provides the technology to offer innovative Radioligand Therapy to treat a variety of cancers such as prostate and neuroendocrine tumors in a more direct and targeted way. Now, we’re able to deliver additional services for our patients—all in one convenient location.”

For more information about AON, visit AONcology.com. To learn more about Florida Oncology and Hematology, visit floridaonc.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Florida Oncology and Hematology
Specialists in the diagnosis and treatment of cancer and blood disorders, Florida Oncology and Hematology serves patients in Cape Coral, Clearwater, Fort Myers, and Naples, Florida. As a community-based practice, it offers a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at floridaonc.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Nevada-based community oncology practice opens its third Nevada location, expanding oncology care access for Clark County area patients

HENDERSON, Nev, July 8, 2025 — Community oncology practice Hope Cancer Care of Nevada, a partner practice of American Oncology Network (AON), is pleased to announce that patients now have an additional choice for oncology and hematology services in Clark County due to its continued expansion in Nevada with a new location opening in Henderson. The addition of this clinic – located at 3035 W. Horizon Ridge Parkway, Suite 100 – offers Henderson-area patients another opportunity to choose a community oncology practice that best suits their unique needs.

Board-certified medical oncologist Dr. Raja S. Mehdi is now accepting patients at the new Hope Cancer Care of Nevada – Henderson location. The new clinic includes private exam rooms that provide dedicated space for patient-physician conversations, an infusion room, and a specialty pharmacy for oral oncolytics. New and existing patients can call (702) 508-9128 for more information or to schedule an appointment.

“We’re excited to welcome patients to our new Henderson location, where we will provide the same high-quality care that we do in all of our clinics,” said Dr. Mehdi. “We have a patient-first mindset, and we hold ourselves to a high-standard of continuously providing exceptional, compassionate care, which is the standard in all of Hope Cancer Care of Nevada’s clinic locations. We look forward to serving our patients at our new clinic in Henderson.”

The Hope Cancer Care of Nevada team now includes three Nevada locations. The practice is committed to providing the community with innovative care for cancer and blood disorders that is delivered holistically based on research and evidence-based medicine. Hope Cancer Care of Nevada patients have access to a diverse range of services for diagnosis, treatment, survivorship, and patient support that are close to home, eliminating the need to travel long distances to receive care.

“We are looking forward to welcoming our patients to the new space, where we will continue to prioritize their health and well-being,” said Dr. Medhi. “This new location will allow us to make access to care more convenient for Clark County patients who reside in Henderson, and we look forward to providing them the exceptional, high-quality one-on-one personalized care they have come to expect from Hope Cancer Care of Nevada.”

For more information about AON, visit AONcology.com. To learn more about Hope Cancer Care of Nevada, visit hccnevada.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Hope Cancer Care of NevadaSpecialists in the diagnosis and treatment of cancer and blood disorders, Hope Cancer Care of Nevada providers have been serving patients in the Las Vegas and Pahrump, Nevada areas for 15 years. As a community-based practice, Hope Cancer Care of Nevada offers a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at hccnevada.com/.

Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com